Surgery – Liquid medicament atomizer or sprayer
Reexamination Certificate
1997-03-31
2001-07-03
Lewis, Aaron J. (Department: 3761)
Surgery
Liquid medicament atomizer or sprayer
C128S200230
Reexamination Certificate
active
06253762
ABSTRACT:
BACKGROUND OF THE INVENTION
Drugs for treating respiratory and nasal disorders are frequently administered in aerosol formulations through the mouth or nose. One widely used method for dispensing such aerosol drug formulations involves making a suspension formulation of the drug as a finely divided powder in a liquefied gas known as a propellant. The suspension is stored in a sealed container capable of withstanding the pressure required to maintain the propellant as a liquid. The suspension is dispersed by activation of a dose metering valve affixed to the container.
A metering valve may be designed to consistently release a fixed, predetermined mass of the drug formulation upon each activation. As the suspension is forced from the container through the dose metering valve by the high vapor pressure of the propellant, the propellant rapidly vaporizes leaving a fast moving cloud of very fine particles of the drug formulation. This cloud of particles is directed into the nose or mouth of the patient by a channelling device such as a cylinder or open-ended cone. Concurrently with the activation of the aerosol dose metering valve, the patient inhales the drug particles into the lungs or nasal cavity. Systems of dispensing drugs in this way are known as “metered dose inhalers” (MDI's). See Peter Byron, Respiratory Drug Delivery, CRC Press, Boca Raton, Fla. (1990) for a general background on this form of therapy.
Patients often rely on medication delivered by MDI's for rapid treatment of respiratory disorders which are debilitating and in some cases, even life threatening. Therefore, it is essential that the prescribed dose of aerosol medication delivered to the patient consistently meet the specifications claimed by the manufacturer and comply with the requirements of the FDA and other regulatory authorities. That is, every dose in the can must be the same within close tolerances.
Some aerosol drugs tend to adhere to the inner surfaces, i.e., walls of the can, valves, and caps, of the MDI. This can lead to the patient getting significantly less than the prescribed amount of drug upon each activation of the MDI. The problem is particularly acute with hydrofluoroalkane (also known as simply “fluorocarbon”) propellant systems, e.g., P134a and P227, under development in recent years to replace chlorofluorocarbons such as P11, P114 and P12.
We have found that coating the interior can surfaces of MDI's with a fluorocarbon polymer significantly reduces or essentially eliminates the problem of adhesion or deposition of fluticasone propionate on the can walls and thus ensures consistent delivery of medication in aerosol from the MDI.
SUMMARY OF THE INVENTION
A metered dose inhaler having part or all of its internal surfaces coated with one or more fluorocarbon polymers, optionally in combination with one or more non-fluorocarbon polymers, for dispensing an inhalation drug formulation comprising fluticasone propionate, or a physiologically acceptable solvate thereof, and a fluorocarbon propellant optionally in combination with one or more other pharmacologically active agents or one or more excipients.
REFERENCES:
patent: 2562118 (1951-07-01), Osdal
patent: 2721010 (1955-10-01), Meshberg
patent: 2886217 (1959-05-01), Thiel
patent: 2892576 (1959-06-01), Ward
patent: 2968427 (1961-01-01), Meshberg
patent: 2980301 (1961-04-01), de Gorter
patent: 3049269 (1962-08-01), Gawthrop
patent: 3052382 (1962-09-01), Gawthorp
patent: 3506737 (1970-04-01), Smith et al.
patent: 3611990 (1971-10-01), Paoletti et al.
patent: 3896602 (1975-07-01), Petterson
patent: 3929537 (1975-12-01), Erwin
patent: 3962171 (1976-06-01), Robbins
patent: 4087026 (1978-05-01), Petterson
patent: 4125152 (1978-11-01), Kestner et al.
patent: 4143204 (1979-03-01), Fang
patent: 4180609 (1979-12-01), Vassiliou
patent: 4335121 (1982-06-01), Phillips et al.
patent: 4339483 (1982-07-01), Ueno et al.
patent: 4407481 (1983-10-01), Bolton et al.
patent: 4423823 (1984-01-01), Franek et al.
patent: 4626157 (1986-12-01), Franek et al.
patent: 4741934 (1988-05-01), Terayama et al.
patent: 4819834 (1989-04-01), Thiel
patent: 4826132 (1989-05-01), Moldenhauer
patent: 4861647 (1989-08-01), Ishikawa et al.
patent: 4897439 (1990-01-01), Rau et al.
patent: 4902318 (1990-02-01), Stevens et al.
patent: 4945008 (1990-07-01), Heyes et al.
patent: 4961966 (1990-10-01), Stevens et al.
patent: 4969577 (1990-11-01), Werding
patent: 4980210 (1990-12-01), Heyes
patent: 4992474 (1991-02-01), Skidmore et al.
patent: 5006383 (1991-04-01), Achille et al.
patent: 5043191 (1991-08-01), Endres et al.
patent: 5061140 (1991-10-01), Hamaguchi et al.
patent: 5168107 (1992-12-01), Tannenbaum
patent: 5176132 (1993-01-01), Drought et al.
patent: 5202110 (1993-04-01), Dalby et al.
patent: 5208226 (1993-05-01), Palmer
patent: 5221576 (1993-06-01), Bosc et al.
patent: 5225183 (1993-07-01), Purewal et al.
patent: 5261538 (1993-11-01), Evans et al.
patent: 5270305 (1993-12-01), Palmer
patent: 5340463 (1994-08-01), Layre et al.
patent: 5345980 (1994-09-01), Burt et al.
patent: 5376359 (1994-12-01), Johnson
patent: 5421492 (1995-06-01), Barger et al.
patent: 5468798 (1995-11-01), Leech
patent: 5503144 (1996-04-01), Bacon
patent: 5508023 (1996-04-01), Byron et al.
patent: 5536583 (1996-07-01), Roberts et al.
patent: 5597433 (1997-01-01), Dyble et al.
patent: 5605674 (1997-02-01), Purewal et al.
patent: 5674472 (1997-10-01), Akehurst et al.
patent: 5674473 (1997-10-01), Purewal et al.
patent: 5674592 (1997-10-01), Clark et al.
patent: 5676929 (1997-10-01), Akehurst et al.
patent: 5681545 (1997-10-01), Purewal et al.
patent: 5683676 (1997-11-01), Akehurst et al.
patent: 5683677 (1997-11-01), Purewal et al.
patent: 5695743 (1997-12-01), Purewal et al.
patent: 5720940 (1998-02-01), Purewal et al.
patent: 2130867 (1994-08-01), None
patent: 2252754A (1973-05-01), None
patent: 2227142A (1973-12-01), None
patent: 3619926A1 (1987-01-01), None
patent: 40 23 909 (1990-07-01), None
patent: 4124730C2 (1993-01-01), None
patent: 0 273 980 (1988-07-01), None
patent: 0 297 712 (1989-01-01), None
patent: 0 317 865 (1989-05-01), None
patent: 0335315 (1989-10-01), None
patent: 0338670 (1989-10-01), None
patent: 0 372 777 (1990-06-01), None
patent: 0 384 606 (1990-08-01), None
patent: 0 465 741 (1992-01-01), None
patent: 0 487 200 (1992-05-01), None
patent: 0504112A2 (1992-09-01), None
patent: 0561987B1 (1993-09-01), None
patent: 0561981B1 (1993-09-01), None
patent: 0 609 453 (1994-08-01), None
patent: 0642992A2 (1995-03-01), None
patent: 0 642 992 (1995-03-01), None
patent: 2267496A (1975-12-01), None
patent: 1322084 (1970-03-01), None
patent: 1191700 (1970-05-01), None
patent: 1362495 (1971-08-01), None
patent: 1394327 (1975-05-01), None
patent: 1 588 463 (1976-08-01), None
patent: 2 003 415 (1978-08-01), None
patent: 2 214 891 (1989-09-01), None
patent: 2 216 794 (1989-10-01), None
patent: 01214433 (1989-08-01), None
patent: 02067374 (1990-03-01), None
patent: 03093525 (1991-04-01), None
patent: 04353442 (1992-12-01), None
patent: 06142799 (1994-05-01), None
patent: WO8101375 (1981-05-01), None
patent: WO9104011 (1991-04-01), None
patent: 91/10606 (1991-07-01), None
patent: WO9208446 (1992-05-01), None
patent: 92/11190 (1992-07-01), None
patent: 9311745 (1993-06-01), None
patent: 9311744 (1993-06-01), None
patent: 93/11743 (1993-06-01), None
patent: WO9403153 (1994-02-01), None
patent: 94/00921 (1994-06-01), None
patent: 94/22722 (1994-10-01), None
Budavari,The Merck Index,Eleventh Ed., Merck & Co., Inc., pp. 37, 158-159, and 663-664 (1989).
Henry,The British Medical Assoc. Guide to Medicines&Drugs,Korling Kindersley, London, p. 137 (1992).
Köhler,Aerosols in Medicine,Chapter 12, pp. 303-319 (1993).
Buckton,International J. Pharm.,vol. 83, pp. 163-170 (1992).
Journal of Teflon,vol. 4, No. 7, pp. 1, 4-6 (1963).
Journal of Teflon,vol. 1, No. 4, pp. 1 and 7 (1960).
Encyc. of Polymer Science and Eng.,vol. 16, pp. 577-642 (1989).
Kunststoff-Handbuch,Band XI,Section 4.3.6.2, pp. 362-363 (1971).
Kirk-Othmer Encyc. of Chem. Technology,vol. 11, Third Edition, pp. 1-49 (1980).
Byron,Respira
Dadswell Charles E.
Glaxo Wellcome Inc.
Lewis Aaron J.
LandOfFree
Metered dose inhaler for fluticasone propionate does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Metered dose inhaler for fluticasone propionate, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Metered dose inhaler for fluticasone propionate will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2552291